KRYS
#907
Krystal Biotech, Inc. - Common Stock
331.6 1 USD
+0.01%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
+1.32%
Variación mensual
-5.46%
Variación en los últimos 6 meses
+27.98%
Cambio anual
+77.21%
Cierres anteriores
327.3 0
Open
326.5 5
Mínimo
323.8 7
Máximo
333.4 4
Financials
- Market Capitalization 9.82 B
- Employee 295
- Founded 2016
- CEO N/A
- Website www.krystalbio.com
- Headquarter Pennsylvania, United States
- FIGI BBG00HDGRHH7
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
36.04
Relación precio/flujo de caja
18.98
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 859 |  BMRN BioMarin Pharmaceutical Inc. - Common Stock | 54.80 USD | -0.16% | -4.04% | -17.59% | +4.68% | 10.61 B USD | ||
| 890 |  KNSA Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares | 79.78 USD | +1.31% | +5.02% | +2.43% | +101.24% | 10.15 B USD | ||
| 931 |  KYMR Kymera Therapeutics, Inc. - Common Stock | 112.40 USD | +2.84% | +3.71% | -3.10% | +90.19% | 9.35 B USD | ||
| 933 |  PTGX Protagonist Therapeutics, Inc. - Common Stock | 143.73 USD | +2.73% | +2.04% | -4.13% | +91.31% | 9.30 B USD |